Navigation
Navigation

Capital for Innovation, Impact and Growth

Capricorn Partners is an independent manager of private and quoted equity funds that invest in minority shareholding positions of innovative companies with technology as competitive advantage.

Venture Capital

Through our private venture capital funds, we invest in promising companies with technological advantages in sustainable chemistry, cleantech, health-tech, digital technologies and artificial intelligence. We are convinced that by investing in new technologies and innovations we can make a positive impact on our society and contribute to a better and more sustainable world, whilst achieving an acceptable return.

We support the growth of our portfolio companies as active value adding shareholders towards successful businesses and profitable exits.

Quoted Equity

Through our Quest Funds, we invest in best-of-class quoted and unquoted companies, managed by our dedicated team of specialists, focused on financial strength, growth prospects, market position, management strength and valuation.

Sequana Medical announces first-in-human data of Direct Sodium Removal (DSR) therapy published in Circulation

News
- 10/01/2020

Positive pre-clinical and clinical proof-of-concept data of Sequana Medical’s innovative DSR therapy published in top tier peer-reviewed cardiovascular journal Data demonstrates potential for treatment of volume overload due to heart failure Ghent, Belgium: 10 January…

Read more

Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients

News
- 07/01/2020

The study aims to: Evaluate the safety of alfapump DSR in patients with heart failure Assess the feasibility of alfapump DSR to remove excess sodium and fluid from the body Explore the potential impact of…

Read more

FEops Awarded Euro 3.2 Million Grant From EU

News
- 10/12/2019

Ghent, Belgium: 10 December 2019 - FEops, a leader in personalized predictive planning for structural heart interventions, has been awarded a grant of Euro 3.2 million from the European Innovation Council (EIC) accelerator programme. “We…

Read more